Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (789)	2/11/2005 2:18:47 PM
From: Jibacoa	Read Replies (2) of 3722

ALTH is having a nice movement today on increasing volume.It had a couple of good up-ticks at 11.21 and 11.22AM. and it is now trading at its intra-day H of $2.62 bigcharts.marketwatch.com The volume hasn't been yet as good as the one on Dec.9(3,518,101) when the stock went from $1.98 to $2.75 or the one on Dec.10(3,275,131) when the stock opened with an up-gap at $3.02(albeit that was the intra-day H an it closed at $2.53 <g>) The stock is up 10.21% on volume of 313,184 which is already more than 3x yesterday's volume of 84,475 ALTH has no revenues but has been cutting its loss. It has no significant LTD and reportedly has about $0.90 in cash/share. Back in Dec. it presented some of the results of its PIII on brain metastases from breast Ca treated with its EFAPROXYN which is a small molecule designed to "sensitize" hypoxic areas of tumors to make them more sensitive to radiation therapy.It doesn't have to cross the blood brain barrier or enter the tumor to be effective. The stock needs to close above its Jan.19 H of $2.70 before trying to test the resistance at the $2.75 and $3.02 levels. bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next